Evolving Minds By Pink Elephant

In this exclusive interview, Pink Elephant’s Investment Director Natalia Fedulova sits down with Jason Najum to announce the launch of the Elephant Gate Accelerator. With a decade of experience in venture capital across the globe, Natalia discusses why Pink Elephant is focused on essential infrastructure needed to turn psychedelic medicine into a scalable reality.  #PsychedelicAccelerator #MentalH...

In this exclusive interview, veteran biotech executive Doug Drysdale sits down with Jason Najum from Pink Elephant to discuss the strategy that steered Cybin through the 'biotech winter.' Although Doug stepped down as CEO in September 2025 and the company has since rebranded to Helus Pharma, his insights reveal the critical data-driven decisions that allowed the company to survive and ev...

Go beyond the FDA approval headlines and into the REAL business of psychedelic medicine. While most eyes are on the drug developers, venture capitalist Maria Velkova shares where the smart money is going. The Tabula Rasa Ventures managing partner tells the untold story of the critical infrastructure needed for psychedelics to succeed post-approval, Big Pharma’s recent entry into the space, the mat...

Go inside the REAL business of psychedelic medicine. While everyone talks about investment and FDA headlines, George McBride is on the front lines doing the essential work. The Clerkenwell Health co-founder reveals the untold story of navigating psychedelic clinical trials, Big Pharma’s growing interest, public-private partnerships with the NHS, the future of AI in psychedelic clinical trials, and...

Today’s guest is Ronan Levy, co-founder and former CEO of Field Trip Health, joins Jason Najum to reflect on the explosive rise and collapse of one of the first public psychedelic therapy companies. #PsychedelicStartups #KetamineClinics #mentalhealthinnovation  #mentalhealthpodcast  In this raw and insightful conversation, Ronan shares: - How Field Trip raised $100M and listed on the NASDAQ - Why...